Abeona Therapeutics (ABEO) Change in Receivables (2011 - 2026)
Abeona Therapeutics (ABEO) recorded quarterly Change in Receivables of $53000.0 in Q1 2026, up 105.06% quarter-over-quarter from -$1.0 million in Q4 2025, and up 251.43% on a YoY basis from $15081.3 in Q1 2025.
Abeona Therapeutics (ABEO) Change in Receivables (2011 - 2026) Analysis & Trends
Abeona Therapeutics' Change in Receivables history runs 14 years deep, the most recent figure standing at $53000.0 for Q1 2026.
- In Q1 2026, Change in Receivables rose 251.43% year-over-year to $53000.0; the TTM figure through Mar 2026 stood at -$996000.0 (down 73.22% YoY), while the FY2025 annual figure was -$1.1 million, down 36.87% from the prior year.
- Change in Receivables was $53000.0 for Q1 2026 at Abeona Therapeutics, up from -$1.0 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $4.8 million in Q2 2022 to a low of -$4.8 million in Q3 2022.
- Historically, Change in Receivables has averaged -$173875.0 across 5 years, with a median of -$16000.0 in 2023.
- The sharpest annual moves came in 2025 and 2026: Change in Receivables slumped 2787.18% in 2025, then surged 251.43% in 2026.
- A 5-year view of Change in Receivables shows it stood at -$4.8 million in 2022, then surged by 100.41% to $20000.0 in 2023, then surged by 95.0% to $39000.0 in 2024, then plunged by 2787.18% to -$1.0 million in 2025, then surged by 105.06% to $53000.0 in 2026.
- The last three Change in Receivables figures came in at $53000.0 (Q1 2026), -$1.0 million (Q4 2025), and -$14000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -4.08 Mn |
| 10 | Abeona Therapeutics | 309.15 Mn | 140.88 Mn | 6.02 Mn | 53,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53,000.00 |
| Mar 31, 2026 | 53,000.00 |
| Dec 31, 2025 | -1.05 Mn |
| Dec 31, 2025 | -1.05 Mn |
| Sep 30, 2025 | -14,000.00 |
| Sep 30, 2025 | -14,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | -35,000.00 |
| Mar 31, 2025 | -35,000.00 |
| Dec 31, 2024 | 39,000.00 |
| Dec 31, 2024 | 39,000.00 |
| Sep 30, 2024 | -27,000.00 |
| Sep 30, 2024 | -27,000.00 |
| Jun 30, 2024 | -552,000.00 |
| Jun 30, 2024 | -552,000.00 |
| Mar 31, 2024 | -252,000.00 |
| Mar 31, 2024 | -252,000.00 |
| Dec 31, 2023 | 20,000.00 |
| Dec 31, 2023 | 20,000.00 |